Independent Lab Report – Dragon Pharma S23 Verified at 12.43mg/tab
In today’s performance research landscape, S-23 has earned its name as one of the most potent SARMs, often compared to traditional anabolic compounds for its strength and hardness effects. With growing demand comes the need for verifiable purity — and this recent lab result once again demonstrates
Dragon Pharma’s consistency and transparency when it comes to product quality.
Laboratory Overview
This test was conducted by
Analiza Białek Laboratory, an independent analytical facility based in Wrocław, Poland, known for peptide, hormone, and SARM analysis.
The sample tested was
Dragon Pharma S23 (15mg/tab), submitted by the manufacturer for verification.
Key Details:
Client: Dragon Pharma
Batch Number: HD523923
Order Number: 100007675
Receive Date: 2025-04-11
Start Date: 2025-04-16
End Date: 2025-04-18
Form: Green tablets in a string bag
Test Method: BioBasic 8 Thermo Scientific column
Password for verification:
2S9MFY73
Results Summary
Substance Sample Name Labeled Content Tested Content
S-23 Dragon Pharma S23 15mg/tab 15mg/tab
12.43mg/tab ±0.05mg
The analysis found the tablets to contain 12.43mg of active S-23 per tab, which corresponds to roughly 83% of the labeled claim. Considering analytical tolerances and formulation factors, this still falls within a realistic and functionally potent range — confirming that the compound is genuine and active.
Research Comment & Interpretation
The lab used a linear gradient solution of H₂O and Acetonitrile with 0.1% trifluoroacetic acid for separation. A clear peak corresponding to S-23 was identified, and quantification matched known chromatographic standards.
The measured content (12.43mg) indicates the batch contains true S-23 with a slight underfill margin, a common characteristic in pressed tablets where excipients or binding density can slightly affect per-tablet concentration. What’s important is that the compound tested positive for accurate S-23 presence, with no contamination or mismatched peaks reported.
What This Means for Researchers
From a research perspective, this verification gives confidence that Dragon Pharma’s S23 is legitimate and within expected potency variation.
S-23 is often explored for its:
Potent anabolic-to-androgenic ratio
Lean mass retention during caloric deficit
Hardening and vascularity effects
Experimental potential as a non-steroidal androgen receptor modulator
Users or researchers should still account for the slightly reduced potency when planning equivalent dosing. For example, a 15mg theoretical dose would equal approximately 12.4mg of active S-23, based on this report.
Visual Verification
The tested sample matches Dragon Pharma’s current packaging — green tablets labeled
S23 (Mastorin), confirming authenticity and alignment with legitimate branding.
Conclusion
The Dragon Pharma S23 batch (HD523923) tested positive for genuine S-23 with a concentration of
12.43mg/tab. While marginally below the 15mg label, the result shows true active compound presence and confirms that Dragon Pharma continues to uphold transparency through third-party lab verification.
As always, if you’re looking into research-based SARMs or comparison data, Dragonpharmastore remains one of the few platforms maintaining public lab documentation — a solid move toward keeping the community informed and product quality verifiable.
Official Dragonpharmastore Lab Test Results Thread
Latest Lab Verified: Dragon Pharma Enclomiphene 25mg
Product Tested:
Interpretation:
Verified Potency: Dragon Pharma SLU-PP-332 (Lab Certified)
Verified Potency Report: Dragon Pharma Oxymetholon 50mg
Why It Matters
Summary Snapshot
Laboratory Report Summary
Photo of lab report
Final Thoughts
Fresh Janoshik Lab Report – GHK-CU (Dragon Pharma)
Note
Transparency & Verification 
